MENU

Fox Chase Cancer Center News

Mark Sobczak, MD, FACR
June 19, 2019

Mark Sobczak Named a 2019 Fellow of the American College of Radiology

PHILADELPHIA (June 19, 2019)— Mark Sobczak, MD, FACR, clinical director in the Department of Radiation Oncology at Fox Chase Cancer Center, was selected as a 2019 Fellow of the American College of Radiology (ACR).

Study author Robert G. Uzzo, MD, FACS, Chair of the Department of Surgical Oncology at Fox Chase Cancer Center
June 19, 2019

Cancer Prediction Models May Provide False Sense of Reliability for Guiding Care

PHILADELPHIA (June 19, 2019) — Many of the prediction models used by clinicians to guide patient care and clinical trial selection for solid tumors may not be as accurate as they are thought to be, according to a new study by researchers at Fox Chase Cancer Center.

June 18, 2019

Fox Chase Cancer Center Welcomes Assistant Professor Asya Varshavsky-Yanovsky

PHILADELPHIA (June 18, 2019) – Asya Varshavsky-Yanovsky, MD, PhD, will join the faculty as assistant professor in the Hematology and Bone Marrow Transplant Programs within the Department of Hematology/Oncology, on July 1, 2019.

Joseph R. Testa, PhD, FACMG
June 14, 2019

Common Mutations May Work in Tandem to Drive Development of Malignant Mesothelioma

PHILADELPHIA (June 14, 2019) – Researchers at Fox Chase Cancer Center have found that the combined loss of function of three genes commonly associated with pleural malignant mesothelioma – Bap1, Nf2, Cdkn2a – contributed to rapid and aggressive development of the disease in an animal study.

Jose Russo, MD, FACP, director of the Irma H. Russo, MD, Breast Cancer Research Lab
June 14, 2019

Giving Birth at a Young Age Protects Mothers Against Developing Breast Cancer

PHILADELPHIA (June 14, 2019) – It has been observed for nearly 300 years that women who have their first child at a young age carry a decreased risk for developing breast cancer throughout their lives. The Irma H. Russo, MD, Breast Cancer Research Lab at Fox Chase Cancer Center, and colleagues have recently demonstrated the biological basis for this naturally protective process.

Jessica Bauman, MD
June 13, 2019

Jessica Bauman Shares NIH Research Grant to Test Palliative Care Innovations for Head and Neck Cancer Patients

PHILADELPHIA (June 13, 2019) — Jessica Bauman, MD, an assistant professor in the Department of Hematology/Oncology at Fox Chase Cancer Center, recently received a grant in conjunction with the University of Colorado Denver from the National Institute of Nursing Research.

CEO Cancer Gold Standard re-accreditation
June 7, 2019

Fox Chase Cancer Center Earns CEO Cancer Gold Standard™ Re-Accreditation

PHILADELPHIA (June 7, 2019) – Fox Chase Cancer Center has earned CEO Cancer Gold Standard re-accreditation for maintaining a strong commitment to the health of its employees and satisfying the latest comprehensive requirements of the Gold Standard.

May 23, 2019

Combination of Axitinib and Nivolumab Safe for Patients with Metastatic Renal Cell Carcinoma, Efficacy Testing Ongoing

PHILADELPHIA (May 23, 2019) — A new combination of established kidney cancer drugs has demonstrated safety and encouraging efficacy in patients with metastatic renal cell carcinoma (mRCC),  according to a new clinical trial lead by Matthew Zibelman, MD, on the combination of Axitinib and the PD-1 inhibitor Nivolumab.

Pages

Connect with Fox Chase